Morgan Stanley’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
124,919
+42,627
| +52% | +$88.2K | ﹤0.01% | 5748 |
|
|
2025
Q1 | $138K | Sell |
82,292
-8,759
| -10% | -$14.7K | ﹤0.01% | 5875 |
|
|
2024
Q4 | $200K | Buy |
91,051
+6,738
| +8% | +$14.8K | ﹤0.01% | 5785 |
|
|
2024
Q3 | $126K | Buy |
84,313
+25,856
| +44% | +$38.5K | ﹤0.01% | 5909 |
|
|
2024
Q2 | $116K | Buy |
58,457
+4,412
| +8% | +$8.74K | ﹤0.01% | 5912 |
|
|
2024
Q1 | $166K | Buy |
54,045
+21,709
| +67% | +$66.6K | ﹤0.01% | 5789 |
|
|
2023
Q4 | $224K | Buy |
32,336
+31,936
| +7,984% | +$221K | ﹤0.01% | 5896 |
|
|
2023
Q3 | $1.37K | Buy |
+400
| New | +$1.37K | ﹤0.01% | 7191 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$2 | – | 7770 |
|
|
2022
Q4 | $2 | Sell |
1
-2
| -67% | -$4 | ﹤0.01% | 7856 |
|
|
2022
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7790 |
|